Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients

Clinical trial NCT04673591 · COMPLETED

Trial details

NCT number: NCT04673591
Sponsor: T-Balance Therapeutics GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergy to House Dust Mite Allergic Asthma

Start date: 2020-12-09
Primary completion: 2022-01-12
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.